Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Novartis Ag Sponsored ADR(NVS US)

$151.12-5.153.30%Ext:$157.00+5.883.89%(Market Closed · 00:00:04 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
NVS US​

SEC Filings

Financials(28)

Expand
  • 20-FFY 2025ended 31 Dec 20254 Feb
  • 20-FFY 2024ended 31 Dec 202431 Jan 2025
  • 20-FFY 2023ended 31 Dec 202331 Jan 2024
  • 20-F/AFY 2022ended 31 Dec 202215 May 2023
  • 20-FFY 2022ended 31 Dec 20221 Feb 2023
  • 20-F/AFY 2021ended 31 Dec 202126 Apr 2022
  • 20-FFY 2021ended 31 Dec 20212 Feb 2022
  • 20-FFY 2020ended 31 Dec 202026 Jan 2021
  • 20-FFY 2019ended 31 Dec 201929 Jan 2020
  • 20-FFY 2018ended 31 Dec 201830 Jan 2019
  • 20-FFY 2017ended 31 Dec 201724 Jan 2018
  • 20-FFY 2016ended 31 Dec 201625 Jan 2017
  • 20-FFY 2015ended 31 Dec 201527 Jan 2016
  • 20-FFY 2014ended 31 Dec 201427 Jan 2015
  • 20-FFY 2013ended 31 Dec 201329 Jan 2014

Events(937)

Expand
  • 6-KCurrent report (foreign private issuer)8 Sep
  • 6-KCurrent report (foreign private issuer)4 Sep
  • 6-KCurrent report (foreign private issuer)1 Sep
  • 6-KCurrent report (foreign private issuer)21 Jul
  • 6-KCurrent report (foreign private issuer)11 Jun
  • 6-KCurrent report (foreign private issuer)28 Apr
  • 6-KCurrent report (foreign private issuer)18 Mar
  • 6-KCurrent report (foreign private issuer)4 Feb
  • 6-KCurrent report (foreign private issuer)4 Feb
  • 6-KCurrent report (foreign private issuer)24 Nov 2025
  • 6-KCurrent report (foreign private issuer)20 Nov 2025
  • 6-KCurrent report (foreign private issuer)5 Nov 2025
  • 6-KCurrent report (foreign private issuer)28 Oct 2025
  • 6-KCurrent report (foreign private issuer)27 Oct 2025
  • 6-KCurrent report (foreign private issuer)30 Sep 2025

Insider Ownership(134)

Expand
  • 3NOVARTIS AG28 Oct 2025
  • 3NOVARTIS AG27 Jun 2022
  • 3Initial statement of beneficial ownership14 Aug 2020
  • 4Statement of changes in beneficial ownership16 Jul 2020
  • 3Initial statement of beneficial ownership13 Jul 2020
  • 4Statement of changes in beneficial ownership2 Jul 2020
  • 3Initial statement of beneficial ownership25 Jun 2020
  • 4NOVARTIS AG22 Jun 2020
  • 3Initial statement of beneficial ownership18 Jun 2020
  • 4NOVARTIS AG17 Jun 2020
  • 4NOVARTIS AG12 Jun 2020
  • 4NOVARTIS AG9 Jun 2020
  • 4NOVARTIS AG4 Jun 2020
  • 4Statement of changes in beneficial ownership12 Nov 2019
  • 3Initial statement of beneficial ownership6 Nov 2019

Beneficial Ownership(54)

Expand
  • SC 13GNOVARTIS AG17 Jul 2025
  • SC 13D/AMorphoSys AG17 Oct 2024
  • SC 13D/AMorphoSys AG15 Aug 2024
  • SC 13D/AMorphoSys AG21 Jun 2024
  • SC 13D/AMorphoSys AG17 Jun 2024
  • SC 13D/AMorphoSys AG10 Jun 2024
  • SC 13D/AMorphoSys AG28 May 2024
  • SC 13DMorphoSys AG18 Apr 2024
  • SC 13G/ANOVARTIS AG2 Feb 2024
  • SC 13G/ANOVARTIS AG1 Feb 2023
  • SC 13GNOVARTIS AG4 Feb 2022
  • SC 13G/AXOMA Corp19 Aug 2020
  • SC 13GresTORbio, Inc.14 Feb 2018
  • SC 13DAdvanced Accelerator Applications S.A.1 Feb 2018
  • SC 13G/AADURO BIOTECH, INC.19 Dec 2017

Other Ownership(8)

Expand
  • 144Bulto Carulla Victor30 Apr
  • 144Marshall Fiona12 Feb
  • 144Bulto Carulla Victor9 Feb
  • 144Marshall Fiona23 May 2025
  • 144Kowalski Robert William30 Apr 2025
  • 144Kowalski Robert William12 Aug 2024
  • 144Gal Aharon22 May 2024
  • 144Kowalski Robert William19 Sep 2023

Proxies(15)

Expand
  • DFAN14ADefinitive additional soliciting materials14 Jan
  • DFAN14ADefinitive additional soliciting materials12 Jan
  • DFAN14ADefinitive additional soliciting materials28 Oct 2025
  • DFAN14ADefinitive additional soliciting materials28 Oct 2025
  • DFAN14ADefinitive additional soliciting materials27 Oct 2025
  • DFAN14ADefinitive additional soliciting materials27 Oct 2025
  • DFAN14ADefinitive additional soliciting materials27 Oct 2025
  • DFAN14ADefinitive additional soliciting materials10 Jul 2023
  • DFAN14ADefinitive additional soliciting materials12 Jun 2023
  • DFAN14ADefinitive additional soliciting materials6 Nov 2018
  • DFAN14ADefinitive additional soliciting materials5 Nov 2018
  • DFAN14ADefinitive additional soliciting materials18 Oct 2018
  • DFAN14ADefinitive additional soliciting materials18 Oct 2018
  • DFAN14ADefinitive additional soliciting materials18 Oct 2018
  • DFAN14ADefinitive additional soliciting materials18 Oct 2018

Registrations(83)

Expand
  • 424B5Prospectus filing (Rule 424(b)(5))17 Mar
  • FWPFree writing prospectus16 Mar
  • 424B5Prospectus filing (Rule 424(b)(5))16 Mar
  • S-8Registration statement (employee benefit plan)4 Feb
  • S-8 POSPost-effective amendment (employee benefit plan)16 Jan
  • S-8 POSPost-effective amendment (employee benefit plan)16 Jan
  • S-8 POSPost-effective amendment (employee benefit plan)16 Jan
  • S-8 POSPost-effective amendment (employee benefit plan)16 Jan
  • 424B5Prospectus filing (Rule 424(b)(5))4 Nov 2025
  • FWPFree writing prospectus3 Nov 2025
  • 424B5Prospectus filing (Rule 424(b)(5))3 Nov 2025
  • 424B5Prospectus filing (Rule 424(b)(5))17 Sep 2024
  • 424B5Prospectus filing (Rule 424(b)(5))16 Sep 2024
  • F-3ASRAutomatic shelf registration statement (F-3)16 Sep 2024
  • FWPFree writing prospectus16 Sep 2024

Filing Review Correspondence(22)

Expand
  • CORRESPFiling review correspondence31 Mar 2025
  • CORRESPFiling review correspondence9 May 2023
  • CORRESPFiling review correspondence19 Jan 2021
  • CORRESPFiling review correspondence21 Dec 2017
  • CORRESPFiling review correspondence20 Apr 2017
  • CORRESPFiling review correspondence27 Mar 2017
  • CORRESPFiling review correspondence20 Jul 2015
  • CORRESPFiling review correspondence29 Jun 2015
  • CORRESPFiling review correspondence24 Apr 2015
  • CORRESPFiling review correspondence7 Apr 2015
  • CORRESPFiling review correspondence23 Aug 2013
  • CORRESPFiling review correspondence17 Jul 2013
  • CORRESPFiling review correspondence2 Jul 2013
  • UPLOADFiling review upload19 Jun 2013
  • CORRESPFiling review correspondence23 May 2013

SEC Orders And Notices(3)

Expand
  • CT ORDERConfidential treatment order17 Feb 2016
  • CT ORDERConfidential treatment order14 May 2015
  • EFFECTNotice of effectiveness25 Feb 2011

Tender Offers And Going Private(71)

Expand
  • SC TO-T/ATender offer statement (third-party, amendment)28 Oct 2025
  • SC TO-T/ATender offer statement (third-party, amendment)22 Oct 2025
  • SC TO-T/ATender offer statement (third-party, amendment)20 Oct 2025
  • SC TO-TTender offer statement (third-party)29 Sep 2025
  • SC TO-CTender offer statement (communication)9 Sep 2025
  • SC TO-T/ATender offer statement (third-party, amendment)25 Jun 2025
  • SC TO-T/ATender offer statement (third-party, amendment)23 Jun 2025
  • SC TO-T/ATender offer statement (third-party, amendment)17 Jun 2025
  • SC TO-TTender offer statement (third-party)27 May 2025
  • SC TO-CTender offer statement (communication)1 May 2025
  • SC TO-CTender offer statement (communication)30 Apr 2025
  • SC TO-T/ATender offer statement (third-party, amendment)13 Aug 2024
  • SC TO-T/ATender offer statement (third-party, amendment)7 Aug 2024
  • SC TO-T/ATender offer statement (third-party, amendment)2 Aug 2024
  • SC TO-T/ATender offer statement (third-party, amendment)1 Aug 2024

Other(25)

Expand
  • IRANNOTICEIRANNOTICE4 Feb
  • IRANNOTICEIRANNOTICE31 Jan 2025
  • SDSD31 May 2024
  • IRANNOTICEIRANNOTICE31 Jan 2024
  • SDSD31 May 2023
  • IRANNOTICEIRANNOTICE1 Feb 2023
  • SDSD31 May 2022
  • IRANNOTICEIRANNOTICE2 Feb 2022
  • SDSD1 Jun 2021
  • IRANNOTICEIRANNOTICE26 Jan 2021
  • SDSD1 Jun 2020
  • IRANNOTICEIRANNOTICE29 Jan 2020
  • SDSD31 May 2019
  • IRANNOTICEIRANNOTICE30 Jan 2019
  • SDSD31 May 2018